Skip to main content

National Institutes of Health — Portfolio, Page 8

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

491
Companies
$2.5B
Total invested
$5.9M
Avg. check
26
Industries
Health Care 18Biotechnology 14Medical 8Therapeutics 7Medical Device 6Health Diagnostics 5+20 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 169192 of 491
Trefoil Therapeutics
May 2025

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

Biotechnology · San Diego$4.6M Venture - Series Unknown
Epicore Biosystems
May 2025

Epicore Biosystems is a digital health solutions company that develops sweat-sensing wearables, providing personalized health insights.

Health Care · Cambridge$6.0M Series B
Ria Health
February 2025

Ria Health is an online platform providing telehealth services for alcohol use disorder.

Health Care · San Francisco$6.5M Series B
PEEL Therapeutics
February 2025

Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.

Biotechnology · Salt Lake CitySeries A
iotaMotion
January 2025

IotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery.

Biotechnology · Iowa City$6.4M Series B
Teal Health
January 2025

Teal Health is a health tech company that develops cervical cancer screening and communication platforms.

Health Care · San Francisco$10.0M Seed
PhotoniCare
December 2024

PhotoniCare is a medical device company that develops diagnostic tools to improve clinical outcomes and address unmet patient needs.

Health Care · Champaign$4.6M Series B
Zenflow
November 2024

Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.

Health Care · South San Francisco$24.0M Series C
NextStep Robotics
November 2024

NextStep Robotics is developing the first effective treatment option for foot drop to help stroke survivors.

Artificial Intelligence (AI) · Baltimore$200K Seed
Sonavex
October 2024

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

Biotechnology · Baltimore$15.0M Series A
Modality.AI, Inc.
October 2024

Self-Driven Neurological Assessments

Artificial Intelligence (AI) · San Francisco$571K Seed
EndoTheia
September 2024

EndoTheia is a medical equipment manufacturing firm that supplies the next generation of flexible endoscopic devices.

Health Care · Nashville$500K Venture - Series Unknown
ONL Therapeutics
September 2024

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Biotechnology · Ann Arbor$65.0M Series D
Inflammatix
September 2024

Inflammatix develops rapid immune system diagnostics to improve patient care and public health.

Bioinformatics · Burlingame$57.0M Series E
CoapTech
September 2024

CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world.

Biotechnology · Baltimore$7.1M Venture - Series Unknown
Kinoxis Therapeutics
August 2024

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

Biotechnology · Melbourne$9.5M Series B
Magnetic Insight
July 2024

Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.

Biotechnology · AlamedaSeries B
Spinogenix
June 2024

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

Biotechnology · San Diego$2.8M Venture - Series Unknown
Envisagenics
June 2024

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Artificial Intelligence (AI) · Long Island City$25.0M Series B
Raydiant Oximetry
June 2024

Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.

Biotechnology · San Ramon$7.5M Series A
Genomenon
May 2024

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

Developer Tools · Ann Arbor$5.5M Venture - Series Unknown
SeLux Diagnostics
April 2024

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Biotechnology · Charlestown$48.0M Series D
Sapphiros
January 2024

Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.

Business Development · Boston$30.0M Series B
Soterya
November 2023

AI-Driven Robotic Medical Technologies for Sleep Health

Artificial Intelligence (AI) · Everett$3.0M Seed

Where National Institutes of Health invests

Health Care18
Biotechnology14
Medical8
Therapeutics7
Medical Device6
Health Diagnostics5

About National Institutes of Health's portfolio

How many companies has National Institutes of Health invested in?

National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Institutes of Health invest in?

National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 26 different industry categories.

What is National Institutes of Health's largest investment?

Among tracked funding rounds, ONL Therapeutics received $65.0M in a Series D round. National Institutes of Health's total known invested capital is $2.5B.

What is the average investment size for National Institutes of Health?

National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.

What are National Institutes of Health's most recent investments?

Recent National Institutes of Health portfolio additions include Trefoil Therapeutics, Epicore Biosystems, Ria Health, PEEL Therapeutics, iotaMotion. These companies were founded in 2020 or later.

Reach the founders behind these 491 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →